Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Phase 1b / 2 Study of Rivoceranib and Trifluridine / Tipiracil for Metastatic Colorectal Cancer
Multiple Cancer Types
Comparing the efficacy of rivoceranib and trifluridine / tipiracil administered individually as monotherapies, as well as a rivocernib plus trifluridine / tipiracil combination therapy in the treatment of mCRC that is unresponsive to traditional chemotherapies.
Colon,
Rectal
I/II
Eng, Cathy
NCT04073615
VICCGI1970